quite interesting and promising results for a potential new therapy for diabetes 2 patients.
"Remarkably, at the 6- and 12-month follow-up, 86% of participants (12 out of 14) no longer required insulin therapy, and this success continued through the 24-month follow-up. In these cases, all patients maintained glycaemic control, with HbA1c levels remaining below 7.5%."
https://ueg.eu/a/360?origin=serp_auto
#science #diabetes
AHWhite
npub1c2…kmmvf
2024-10-22 19:41:25
Author Public Key
npub1c2rvx6ue9uewl452kczcfxz9w242sfzn64ul8dv2afd3t5dpktzs0kmmvfPublished at
2024-10-22 19:41:25Event JSON
{
"id": "25f2d7992d35045536221d2b5b1d56991bb4e6d4ec78ddfc333e714d7afa1c81",
"pubkey": "c286c36b992f32efd68ab60584984572aaa82453d579f3b58aea5b15d1a1b2c5",
"created_at": 1729626085,
"kind": 1,
"tags": [
[
"t",
"science"
],
[
"t",
"diabetes"
]
],
"content": "quite interesting and promising results for a potential new therapy for diabetes 2 patients. \n\n\"Remarkably, at the 6- and 12-month follow-up, 86% of participants (12 out of 14) no longer required insulin therapy, and this success continued through the 24-month follow-up. In these cases, all patients maintained glycaemic control, with HbA1c levels remaining below 7.5%.\"\n\nhttps://ueg.eu/a/360?origin=serp_auto\n\n#science #diabetes\n",
"sig": "95ac9569c34c74d67322d541245a16afce7eb2c313efb0246bb47c48b01e2323f11deb1d8f1108968129b8ed8fb0e240b3980a6a30d055ad2c3c49322a25da69"
}